ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Developing Non-Traditional Antibiotics (AAC ed.)"
Episode Synopsis
Developing non-traditional antibiotics promises novel strategies to combat multidrug-resistant organisms but would they work? Are they feasible to develop? Topics discussed:
• The notion of non-traditional antibiotics as potential therapeutics against MDR organisms
• Increasing our understanding on the clinical efficacy of non-traditional antibiotics
• Regulatory pathways for approval of such compounds
Guest: Dr. John Rex, Chief Medical Officer, F2G Ltd. | Editor-in-Chief, AMR.solutions Visit https://aac.asm.org to browse issues and/or submit a manuscript.
More episodes of the podcast Editors in Conversation
Metabolomics
20/11/2025
What Makes a Great Mini-review? (JCM ed.)
29/09/2025
Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)
17/09/2025
The Rise of Measles (AAC ed.)
28/08/2025
In God we trust